| Quarter | Filling ID |
|---|---|
| Q4 25 | 0002002654-26-000001 |
| Q3 25 | 0002002654-25-000006 |
| Q2 25 | 0002002654-25-000004 |
| Q1 25 | 0002002654-25-000003 |
| Q4 24 | 0002002654-25-000001 |
| Q3 24 | 0002002654-24-000005 |
| Q2 24 | 0002002654-24-000004 |
| Q1 24 | 0002002654-24-000002 |
| Q4 23 | 0002002654-24-000001 |
| Q3 23 | 0002002654-23-000008 |
| Q2 23 | 0002002654-23-000007 |
| Q1 23 | 0002002654-23-000006 |
| Q4 22 | 0002002654-23-000005 |
| Q3 22 | 0002002654-23-000004 |
| Q2 22 | 0002002654-23-000003 |
| Q1 22 | 0002002654-23-000002 |
| Q4 21 | 0002002654-23-000001 |
| Name | Title | CUSIP | Ticker | Value | Shares | Share Price | Investment | % of Portfolio |
|---|---|---|---|---|---|---|---|---|
| Seagen Inc. | COM | 81181C104 | $7,465,870 | 47,288,259 | SOLE | |||
| BeiGene, Ltd. | SPONSORED ADR | 07725L102 | $4,004,649 | 11,668,897 | SOLE | |||
| Incyte Corporation | COM | 45337C102 | $2,693,988 | 32,021,732 | SOLE | |||
| Kodiak Sciences Inc. | COM | 50015M109 | $1,314,823 | 14,137,881 | SOLE | |||
| ACADIA Pharmaceuticals Inc. | COM | 4225108 | $1,022,202 | 41,910,704 | SOLE | |||
| BioMarin Pharmaceutical Inc. | COM | 09061G101 | $633,251 | 7,589,294 | SOLE | |||
| Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | $465,723 | 3,540,270 | SOLE | |||
| Invitae Corporation | COM | 46185L103 | $345,684 | 10,248,575 | SOLE | |||
| argenx SE | SPONSORED ADR | 04016X101 | $337,065 | 1,119,557 | SOLE | |||
| Prelude Therapeutics Incorporated | COM | 74065P101 | $289,845 | 10,123,824 | SOLE | |||
| IGM Biosciences, Inc. | COM | 449585108 | $262,588 | 3,156,102 | SOLE | |||
| AbCellera Biologics Inc. | COM | 00288U106 | $229,904 | 10,450,180 | SOLE | |||
| Mirati Therapeutics, Inc. | COM | 60468T105 | $227,722 | 1,409,784 | SOLE | |||
| BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | $200,958 | 12,710,818 | SOLE | |||
| Madrigal Pharmaceuticals, Inc. | COM | 558868105 | $146,038 | 1,499,213 | SOLE | |||
| Apellis Pharmaceuticals, Inc. | COM | 03753U106 | $143,585 | 2,271,917 | SOLE | |||
| Heron Therapeutics, Inc. | COM | 427746102 | $126,204 | 8,131,678 | SOLE | |||
| Amarin Corporation plc | SPONSORED ADR | 23111206 | $115,866 | 26,453,422 | SOLE | |||
| Global Blood Therapeutics, Inc. | COM | 37890U108 | $112,675 | 3,217,441 | SOLE | |||
| Pacific Biosciences of California, Inc. | COM | 69404D108 | $111,973 | 3,201,972 | SOLE | |||
| Immunocore Holdings plc | ADS | 45258D105 | $98,435 | 2,520,730 | SOLE | |||
| Kymera Therapeutics, Inc. | COM | 501575104 | $95,022 | 1,959,211 | SOLE | |||
| Verastem, Inc. | COM | 92337C104 | $87,471 | 21,491,630 | SOLE | |||
| Verve Therapeutics, Inc. | COM | 92539P101 | $85,346 | 1,416,530 | SOLE | |||
| Talis Biomedical Corporation | COM | 87424L108 | $83,550 | 7,574,835 | SOLE | |||
| Cerus Corporation | COM | 157085101 | $81,045 | 13,713,195 | SOLE | |||
| DBV Technologies S.A. | SPONSORED ADR | 23306J101 | $79,794 | 14,614,264 | SOLE | |||
| Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | $75,642 | 3,863,239 | SOLE | |||
| Instil Bio, Inc. | COM | 45783C101 | $75,226 | 3,893,700 | SOLE | |||
| Legend Biotech Corporation | SPONSORED ADS | 52490G102 | $68,329 | 1,664,534 | SOLE | |||
| Neurocrine Biosciences, Inc. | COM | 64125C109 | $65,883 | 676,975 | SOLE | |||
| Nurix Therapeutics, Inc. | COM | 67080M103 | $65,107 | 2,454,082 | SOLE | |||
| Insmed Incorporated | COM PAR $.01 | 457669307 | $61,360 | 2,156,001 | SOLE | |||
| Allakos Inc. | COM | 01671P100 | $60,019 | 703,050 | SOLE | |||
| Zymeworks Inc. | COM | 98985W102 | $59,267 | 1,708,472 | SOLE | |||
| Horizon Therapeutics Public Ltd Co | SHS | G46188101 | $56,101 | 599,110 | SOLE | |||
| Forma Therapeutics Holdings, Inc. | SHS | 34633R104 | $50,399 | 2,024,876 | SOLE | |||
| Immatics N.V. | SHS | N44445109 | $49,725 | 4,282,938 | SOLE | |||
| Insmed Incorporated | Note 0.75% 6/1/2028 | 457669AB5 | $44,063 | 40,000,000 | SOLE | |||
| Merus N.V. | COM | N5749R100 | $42,929 | 2,037,469 | SOLE | |||
| Ultragenyx Pharmaceutical Inc. | COM | 90400D108 | $42,378 | 444,444 | SOLE | |||
| Adaptimmune Therapeutics plc | SPONSORED ADR | 00653A107 | $41,880 | 9,830,877 | SOLE | |||
| Krystal Biotech, Inc. | COM | 501147102 | $41,326 | 607,735 | SOLE | |||
| Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | $38,998 | 2,799,577 | SOLE | |||
| Sarepta Therapeutics, Inc. | DBCV 1.5% 11/15/2024 | 803607AB6 | $38,479 | 29,174,000 | SOLE | |||
| Fulgent Genetics, Inc. | COM | 359664109 | $36,986 | 401,016 | SOLE | |||
| Axsome Therapeutics, Inc. | COM | 05464T104 | $36,365 | 539,057 | SOLE | |||
| Neoleukin Therapeutics, Inc. | COM | 64049K104 | $35,275 | 3,821,740 | SOLE | |||
| BioAtla, Inc. | COM | 09077B104 | $34,964 | 825,000 | SOLE | |||
| ADC Therapeutics SA | SHS | H0036K147 | $34,531 | 1,418,107 | SOLE |